Bullseye Asset Management LLC - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 161 filers reported holding AIMMUNE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bullseye Asset Management LLC ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$969,000
+54.8%
57,989
+33.7%
0.52%
-30.7%
Q1 2020$626,000
-57.0%
43,374
-0.3%
0.75%
-47.0%
Q4 2019$1,456,00043,5121.41%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 414,500$14,280,00013.67%
Burrage Capital Management LLC 332,546$11,456,0009.04%
Penn Mutual Asset Management, LLC 158,783$5,470,0007.72%
First Trust Capital Management L.P. 525,598$18,107,0004.87%
GARDNER LEWIS ASSET MANAGEMENT L P 653,711$22,520,0004.08%
ALPINE ASSOCIATES MANAGEMENT INC. 2,075,100$71,488,0003.76%
S. MUOIO & CO. LLC 90,000$3,101,0003.52%
EQUITEC PROPRIETARY MARKETS, LLC 124,700$4,296,0003.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 501,719$17,284,0003.11%
WATER ISLAND CAPITAL LLC 1,062,245$36,594,0003.11%
View complete list of AIMMUNE THERAPEUTICS INC shareholders